Differential inhibition of transient outward currents of Kv1.4 and Kv4.3 by endothelin

Biochemical and Biophysical Research Communications

Volumn 310, Issue 2, 2003, Pages 634-640

  Hagiwara, Kunie ^a   Nunoki, Kazuo ^a   Ishii, Kuniaki ^b   Abe, Takaaki ^a   Yanagisawa, Teruyuki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

Author keywords

CaMKII; Endothelin; Heart failure; Kv1.4; Kv4.3; Mutagenesis; Phosphorylation; PKC; Transient outward current; Ventricular arrhythmia

Indexed keywords

ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ETA; POTASSIUM CHANNEL; PROTEIN KINASE (CALCIUM,CALMODULIN) II; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENT; INHIBITION KINETICS; MOLECULAR MECHANICS; MUTAGENESIS; NONHUMAN; OOCYTE; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STIMULATION; XENOPUS;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0141458851     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.09.062     Document Type: Article

References (35)

1. Campbell D.L., Rasmusson R.L., Qu Y., Strauss H.C. The calcium-independent transient outward potassium current in isolated ferret right ventricular myocytes. I. Basic characterization and kinetic analysis. J. Gen. Physiol. 101:1993;571-601.
2. Kääb S., Nuss H.B., Chiamvimonvat N., O'Rourke B., Pak P.H., Kass D.A., Marban E., Thomaselli G.F. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ. Res. 78:1996;262-273.
3. + currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ. Res. 73:1993;379-385.
4. Tomaselli G.F., Marban E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc. Res. 42:1999;270-283.
5. Näbauer M., Kääb S. Potassium channel down-regulation in heart failure. Cardiovasc. Res. 37:1998;324-334.
6. + current diversity in mouse ventricular myocytes. J. Physiol. 521:1999;587-599.
7. + currents in mammalian cell lines and cardiac myocytes. Pflügers Arch. 437:1999;381-392.
8. + current in rat ventricle. Am. J. Physiol. Heart Circ. Physiol. 276:1999;H1599-H1607.
9. Näbauer M., Beuckelmann D.J., Überfuhr P., Steinbeck G. Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation. 93:1996;168-177.
10. to) phenotypes and distribution of fast-inactivating potassium channel alpha subunits in ferret left ventricular myocytes. J. Gen. Physiol. 113:1999;581-600.
11. to) in normal and diseased myocardium. J. Mol. Cell. Cardiol. 33:2001;851-872.
12. Barry D.M., Xu H., Schuessler R.B., Nerbonne J.M. Functional knockout of the transient outward current, long-QT syndrome, and cardiac remodeling in mice expressing a dominant-negative Kv4 α subunit. Circ. Res. 83:1998;560-567.
13. Xu H., Li H., Nerbonne J.M. Elimination of the transient outward current and action potential prolongation in mouse atrial myocytes expressing a dominant negative Kv4 α subunit. J. Physiol. 519:1999;11-21.
14. Yan G.-X., Rials S.J., Wu Y., Liu T., Xu X., Marinchak R.A., Kowey P.R. Ventricular hypertrophy amplifies transmural repolarization dispersion and induces early afterdepolarization. Am. J. Physiol. Heart Circ. Physiol. 281:2001;H1968-H1975.
15. + channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome. Circulation. 102:2000;706-712.
16. Sakai S., Miyauchi T., Kobayashi M., Yamaguchi I., Goto K., Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature. 384:1996;353-355.
17. Iwanaga Y., Kihara Y., Hasegawa K., Inagaki K., Yoneda T., Kaburagi S., Araki M., Sasayama S. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats. Circulation. 98:1998;2065-2073.
18. Mishima T., Tanimura M., Suzuki G., Todor A., Sharov V.G., Goldstein S., Sabbah H.N. Effects of long-term therapy with bosentan on the progression of left ventricular dysfunction and remodeling in dogs with heart failure. J. Am. Coll. Cardiol. 35:2000;222-229.
19. Yorikane R., Koike H. The arrhythmogenic action of endothelin in rats. Jpn. J. Pharmacol. 53:1990;259-262.
20. Yorikane R., Koike H., Miyake S. Electrophysiological effects of endothelin-1 on canine myocardial cells. J. Cardiovasc. Pharmacol. 17(Suppl. 7):1991;S159-S162.
21. Becker R., Merkely B., Bauer A., Gellér L., Fazekas L., Freigang K.D., Voss F., Senges J.C., Kuebler W., Schoels W. Ventricular arrhythmias induced by endothelin-1 or by acute ischemia: a comparative analysis using three-dimensional mapping. Cardiovasc. Res. 45:2000;310-320.
22. Marban E. Cardiac channelopathies. Nature. 415:2002;213-218.
23. + channels induced by varying the number of inactivation particles. J. Biol. Chem. 275:2000;9358-9362.
24. Pearson R.B., Kemp B.E. Protein kinase phosphorylation site sequences and consensus specificity motif: tabulations. Methods Enzymol. 200:1991;62-81.
25. 2+/calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy. J. Biol. Chem. 275:2000;15239-15245.
26. Okada H., Ishii K., Nunoki K., Abe T., Taira N. Modulation of transient type K channel cloned from rat heart. Biochem. Biophys. Res. Commun. 189:1992;430-436.
27. 2+/calmodulin-dependent protein kinase. J. Neurosci. 17:1997;3379-3391.
28. Po S.S., Wu R.C., Juang G.J., Kong W., Tomaselli G.F. Mechanism of α-adrenergic regulation of expressed hKv4.3 currents. Am. J. Physiol. Heart Circ. Physiol. 281:2001;H2518-H2527.
29. + current, by PKC. Am. J. Physiol. Heart Circ. Physiol. 273:1997;H1775-H1786.
30. Huang X.Y., Morielli A.D., Peralta E.G. Tyrosine kinase-dependent suppression of a potassium channel by the G protein-coupled m1 muscarinic acetylcholine receptor. Cell. 75:1993;1145-1156.
31. + channels in hippocampus involves a mitogen-activated protein kinase pathway. J. Neurosci. 22:2002;4860-4868.
32. Kääb S., Dixon J., Duc J., Ashen D., Näbauer M., Beuckelmann D.J., Steinbeck G., McKinnon D., Tomaselli G.F. Molecular basis of transient outward potassium current downregulation in human heart failure. A decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation. 98:1998;1383-1393.
33. + currents by angiotensin and endothelin. Am. J. Physiol. Heart Circ. Physiol. 284:2003;H1168-H1181.
34. Russell F.D., Molenaar P. The human heart endothelin system: ET-1 synthesis, storage, release and effect. Trends Pharmacol. Sci. 21:2000;353-359.
35. Duru F., Barton M., Luscher T.F., Candinas R. Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs? Cardiovasc. Res. 49:2001;272-280.